176 related articles for article (PubMed ID: 9581474)
1. Prolidase as a prodrug converting enzyme I. Synthesis of proline analogue of chlorambucil and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1997; 42(1):148-55. PubMed ID: 9581474
[TBL] [Abstract][Full Text] [Related]
2. Prolidase as a prodrug converting enzyme. II. Synthesis of proline analogue of anthraquinone-2-carboxylic acid and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1998; 43():201-9. PubMed ID: 9972056
[TBL] [Abstract][Full Text] [Related]
3. Prolidase as a prodrug converting enzyme. III. Synthesis of proline analogues of melphalan and theirs susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1999; 44():190-9. PubMed ID: 10697434
[TBL] [Abstract][Full Text] [Related]
4. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
[TBL] [Abstract][Full Text] [Related]
5. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule based delivery systems for alkylating antineoplastic compounds.
Bielawski K; Bielawska A
ChemMedChem; 2008 Apr; 3(4):536-42. PubMed ID: 18157855
[TBL] [Abstract][Full Text] [Related]
7. Prolidase-activated prodrug for cancer chemotherapy cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells.
Bielawska A; Bielawski K; Chrzanowski K; Wołczyński S
Farmaco; 2000; 55(11-12):736-41. PubMed ID: 11204951
[TBL] [Abstract][Full Text] [Related]
8. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
Chrzanowski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
[TBL] [Abstract][Full Text] [Related]
9. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
Chrzanowski K; Bielawska A; Pałka J
Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
[TBL] [Abstract][Full Text] [Related]
10. Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.
Mittal S; Song X; Vig BS; Amidon GL
Pharm Res; 2007 Jul; 24(7):1290-8. PubMed ID: 17377743
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.
Chrzanowski K; Bielawska A; Bielawski K; Wołczyński S; Pałka J
Farmaco; 2001 Sep; 56(9):701-6. PubMed ID: 11680815
[TBL] [Abstract][Full Text] [Related]
12. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations.
Lupi A; Tenni R; Rossi A; Cetta G; Forlino A
Amino Acids; 2008 Nov; 35(4):739-52. PubMed ID: 18340504
[TBL] [Abstract][Full Text] [Related]
13. Decreased cytotoxicity and increased antimitotic activity of proline analogue of chlorambucil as a prodrug in breast cancer MCF-7 cells.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Acta Pol Pharm; 2000 Nov; 57 Suppl():103-5. PubMed ID: 11293233
[No Abstract] [Full Text] [Related]
14. The role of prolidase as an enzyme participating in the metabolism of collagen.
Pałka JA
Rocz Akad Med Bialymst; 1996; 41(2):149-60. PubMed ID: 9020526
[TBL] [Abstract][Full Text] [Related]
15. Irreversible inhibition of bovine lung angiotensin I-converting enzyme with p-[N,N-bis(chloroethyl)amino]phenylbutyric acid (chlorambucil) and chlorambucyl L-proline and with evidence that an active site carboxyl group is labeled.
Harris RB; Wilson IB
J Biol Chem; 1982 Jan; 257(2):811-5. PubMed ID: 6274865
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs.
Pedersen PJ; Christensen MS; Ruysschaert T; Linderoth L; Andresen TL; Melander F; Mouritsen OG; Madsen R; Clausen MH
J Med Chem; 2009 May; 52(10):3408-15. PubMed ID: 19402667
[TBL] [Abstract][Full Text] [Related]
17. Cloning of a prolidase gene from Aspergillus nidulans and characterisation of its product.
Jalving R; Bron P; Kester HC; Visser J; Schaap PJ
Mol Genet Genomics; 2002 Apr; 267(2):218-22. PubMed ID: 11976965
[TBL] [Abstract][Full Text] [Related]
18. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
[TBL] [Abstract][Full Text] [Related]
19. Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT).
Springer CJ; Dowell R; Burke PJ; Hadley E; Davis DH; Blakey DC; Melton RG; Niculescu-Duvaz I
J Med Chem; 1995 Dec; 38(26):5051-65. PubMed ID: 8544182
[TBL] [Abstract][Full Text] [Related]
20. Acetylsalicylic acid as a potential regulator of prolidase-convertible pro-drugs in control and neoplastic cells.
Chrzanowski K; Bielawska A; Bielawski K; Pałka J; Wołczyński S
Farmaco; 2004 Sep; 59(9):679-84. PubMed ID: 15337432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
